Shopping Cart
- Remove All
- Your shopping cart is currently empty
IXA6, a novel IRE1/XBP1s agonist with potential vasoprotective activity, activates IRE1-XBP1s signaling and XBP1s transcriptional response, making it useful for studying neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $299 | In Stock |
Description | IXA6, a novel IRE1/XBP1s agonist with potential vasoprotective activity, activates IRE1-XBP1s signaling and XBP1s transcriptional response, making it useful for studying neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. |
In vitro | IXA6 ( 10μM ; 4 or 18h ) selectively activates IRE1-XBP1s signaling, activates IRE1 to reduce APP secretion, and selectively reshapes IRE1-XBP1s-dependent ER protein homeostasis. |
Molecular Weight | 441.93 |
Formula | C22H20ClN3O3S |
Cas No. | 1021106-40-0 |
Storage | store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.